Welcome to our dedicated page for Glimpse Group (The) SEC filings (Ticker: GGRP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Glimpse Group (The)'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Glimpse Group (The)'s regulatory disclosures and financial reporting.
The Glimpse Group, Inc. reported that it received a notice from Nasdaq on March 13, 2026 stating that its common stock no longer meets the Nasdaq Capital Market minimum bid price requirement of $1.00 per share, after trading below that level for 30 consecutive business days.
The company has 180 calendar days, until September 9, 2026, to regain compliance, which would occur if its closing bid price is at or above $1.00 for at least 10 consecutive business days. The shares continue to trade on Nasdaq under the symbol GGRP, and the notice does not immediately affect the company’s business, operations, or SEC reporting obligations.
If compliance is not regained by September 9, 2026, the company may qualify for an additional 180-day period if it meets other Nasdaq Capital Market initial listing standards and notifies Nasdaq of its intention to cure the deficiency, potentially through a reverse stock split. Nasdaq staff could move to delist the shares if the deficiency is not cured or eligibility conditions are not met.